We are proud to share an article that has been published on the CORDIS website in six languages at- https://lnkd.in/grURGgK Multiple Stents System
Frequently Asked Questions
EndoGI privately-owned Israeli company, backed by NGT3VC. EndoGI develops Stenting Placement Delivery Systems for the treatment of biliary and pancreatics stenosis and strictures in one cannulation while keeping the guide wire in place lateral after stent deployment.
EndoGI has received two different FDA marketing clearances-510 (k) regulatory approvals on single and multiple stent and delivery system and has launched initial post regulatory approval clinical studies- First in Human.